Warning over stem cell therapy for musculoskeletal diseases


The use of mesenchymal stem cell therapies in clinical practice without a solid scientific evidence base has the potential to risk patient safety and the credibility of the medical profession, says a leading rheumatologist. Professor David Hunter, Professor of Medicine at University of Sydney and the Royal North Shore Hospital and Consultant Rheumatologist at North ...


Already a member? Login to keep reading


OR
© 2017 the limbic